Prescription Drugs

• Senior GOP Sen. Grassley Tells Democrats to Pass Drug Price Legislation Now

  March 21, 2022: Sen. Chuck Grassley (R-Iowa) acknowledged during a Senate Finance Committee hearing Wednesday that it would be difficult to pass legislation lowering drug prices if his own party regains control of Congress following the 2022 midterm elections. He th...Read more >

• Generic Drug Manufacturer Announces Plans for Low-Cost Insulin

  March 14, 2022: Uninsured and underinsured Americans often pay the highest out-of-pocket costs for their medicine, forcing many to choose between purchasing the medicine they need and covering essential living expenses. However, the country’s first not-for-profit ...Read more >

• Nation Celebrates One Year Since American Rescue Plan Became Law

  March 11, 2022: Exactly one year ago, on March 11, 2021, President Biden signed the American Rescue Plan (ARP) into law to address the health and economic crises caused by the COVID-19 pandemic. Since then, this important legislation has been the cornerstone of the ...Read more >

• Key Senator Still Pushing for Legislation to Lower Drug Prices

  January 28, 2022: Senate Finance Committee Chairman Ron Wyden (OR) told Bloomberg News this week that a new version of the Build Back Better Act could be reintroduced with a focus on lowering prescription drug costs, expanding access to health care and increasing clea...Read more >

• Prices Jump 5% On More Than 450 Prescription Drugs to Start the Year

  January 10, 2022: Pharmaceutical corporations have already raised wholesale prices by a median of 4.9% on more than 450 prescription medicines in 2022, according to a new analysis by Stat. The industry is expected to hike more prices throughout January. In 2021, th...Read more >

• Retirees Applaud HHS Secretary Becerra’s Directive that CMS Reconsider 14% 2022 Medicare Premium Hike

  January 10, 2022: Statement by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding reports that Xavier Becerra, Secretary of the U.S. Department of Health and Human Services, has ordered the Centers for Medicare and Medicaid Services (C...Read more >

• Biogen Cuts Price for Alzheimer’s Drug Amid Controversy

  January 05, 2022: Facing widespread criticism for the exorbitant cost of its new Alzheimer’s drug, Aduhelm, Biogen announced it would cut the price by half, from $56,000 per year to $28,200 per year. Biogen had projected that sales of the drug would generate $12 ...Read more >

• Senate Republicans and Chamber of Commerce Double Down on Opposition to the Build Back Better Act

  December 21, 2021: Last week, Senate Majority Leader Charles Schumer (NY) said that a Senate vote on the Build Back Better Act will not happen this year. The House-passed version of Build Back Better would provide guaranteed hearing care for all Medicare beneficiari...Read more >

• House Oversight Committee: Drug Prices are “Unsustainable, Unjustifiable and Unfair”

  December 13, 2021: The pharmaceutical industry relies on drug-pricing practices that are “unsustainable, unjustified and unfair,” according to findings from a nearly three-year investigation by the House Oversight Committee. The conclusions, released Friday, sho...Read more >

• President Biden Outlines the Ways “Build Back Better” will Lower Drug Prices

  December 13, 2021: President Biden, citing the "outrageously expensive" cost of insulin and other prescription medications, called on Congress last week to pass his Build Back Better bill, which contains multiple provisions to lower drug prices. In his brief remarks...Read more >